Literature DB >> 28452148

Understanding structure-function relationships of the human neuronal acetylcholine receptor: insights from the first crystal structures of neuronal subunits.

Petros Giastas1, Marios Zouridakis1, Socrates J Tzartos1.   

Abstract

Nicotinic ACh receptors (nAChRs) are the best studied members of the superfamily of pentameric ligand-gated ion channels (pLGICs). Neuronal nAChRs regulate neuronal excitability and neurotransmitter release in the nervous system and form either homo- or hetero-pentameric complexes with various combinations of the 11 neuronal nAChR subunits (α2-7, α9, α10 and β2-4) known to exist in humans. In addition to their wide distribution in the nervous system, neuronal nAChRs have been also found in immune cells and many peripheral tissues. These nAChRs are important drug targets for neurological and neuropsychiatric diseases (e.g. Alzheimer's, schizophrenia) and substance addiction (e.g. nicotine), as well as in a variety of diseases such as chronic pain, auditory disorders and some cancers. To decipher the functional mechanisms of human nAChRs and develop efficient and specific therapeutic drugs, elucidation of their high-resolution structures is needed. Recent studies, including the X-ray crystal structures of the near-intact α4β2 nAChR and of the ligand-binding domains of the α9 and α2 subunits, have advanced our knowledge on the detailed structure of the ligand-binding sites formed between the same and different subunits and revealed many other functionally important interactions. The aim of this review is to highlight some of the structural and functional findings of these studies and to compare them with recent breakthrough findings on other pLGIC members and earlier data from their homologous ACh-binding proteins. LINKED ARTICLES: This article is part of a themed section on Nicotinic Acetylcholine Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.11/issuetoc.
© 2017 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28452148      PMCID: PMC5980119          DOI: 10.1111/bph.13838

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  77 in total

Review 1.  Positive and negative modulation of nicotinic receptors.

Authors:  Hugo R Arias
Journal:  Adv Protein Chem Struct Biol       Date:  2010       Impact factor: 3.507

Review 2.  Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.

Authors:  Antoine Taly; Pierre-Jean Corringer; Denis Guedin; Pierre Lestage; Jean-Pierre Changeux
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

3.  Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.

Authors:  Layla Azam; Athanasios Papakyriakou; Marios Zouridakis; Petros Giastas; Socrates J Tzartos; J Michael McIntosh
Journal:  Mol Pharmacol       Date:  2015-03-04       Impact factor: 4.436

4.  Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interface.

Authors:  Philip K Ahring; Jeppe A Olsen; Elsebet Ø Nielsen; Dan Peters; Martin H F Pedersen; Line A Rohde; Jette S Kastrup; Azadeh Shahsavar; Dinesh C Indurthi; Mary Chebib; Michael Gajhede; Thomas Balle
Journal:  Neuropharmacology       Date:  2015-01-13       Impact factor: 5.250

5.  Influence of the M3-M4 intracellular domain upon nicotinic acetylcholine receptor assembly, targeting and function.

Authors:  S Kracun; P C Harkness; A J Gibb; N S Millar
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

6.  The alpha9 nicotinic acetylcholine receptor shares pharmacological properties with type A gamma-aminobutyric acid, glycine, and type 3 serotonin receptors.

Authors:  C V Rothlin; E Katz; M Verbitsky; A B Elgoyhen
Journal:  Mol Pharmacol       Date:  1999-02       Impact factor: 4.436

7.  Crystal structures of free and antagonist-bound states of human α9 nicotinic receptor extracellular domain.

Authors:  Marios Zouridakis; Petros Giastas; Eleftherios Zarkadas; Dafni Chroni-Tzartou; Piotr Bregestovski; Socrates J Tzartos
Journal:  Nat Struct Mol Biol       Date:  2014-10-05       Impact factor: 15.369

8.  Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors.

Authors:  Mark E Nelson; Alexander Kuryatov; Catherine H Choi; Yan Zhou; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2003-02       Impact factor: 4.436

Review 9.  Diversity of vertebrate nicotinic acetylcholine receptors.

Authors:  Neil S Millar; Cecilia Gotti
Journal:  Neuropharmacology       Date:  2008-08-05       Impact factor: 5.250

10.  Crystal structure of Lymnaea stagnalis AChBP complexed with the potent nAChR antagonist DHβE suggests a unique mode of antagonism.

Authors:  Azadeh Shahsavar; Jette S Kastrup; Elsebet Ø Nielsen; Jesper L Kristensen; Michael Gajhede; Thomas Balle
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more
  12 in total

1.  A tale of ligands big and small: an update on how pentameric ligand-gated ion channels interact with agonists and proteins.

Authors:  Stephan A Pless; Lucia G Sivilotti
Journal:  Curr Opin Physiol       Date:  2019-06-12

2.  Nicotinic acetylcholine receptors.

Authors:  Sue Wonnacott; Isabel Bermudez; Neil S Millar; Socrates J Tzartos
Journal:  Br J Pharmacol       Date:  2018-06       Impact factor: 8.739

3.  A triad of residues is functionally transferrable between 5-HT3 serotonin receptors and nicotinic acetylcholine receptors.

Authors:  Richard Mosesso; Dennis A Dougherty
Journal:  J Biol Chem       Date:  2018-01-03       Impact factor: 5.157

Review 4.  Understanding structure-function relationships of the human neuronal acetylcholine receptor: insights from the first crystal structures of neuronal subunits.

Authors:  Petros Giastas; Marios Zouridakis; Socrates J Tzartos
Journal:  Br J Pharmacol       Date:  2017-06-20       Impact factor: 8.739

Review 5.  The α9α10 nicotinic acetylcholine receptor: a compelling drug target for hearing loss?

Authors:  Ana Belén Elgoyhen
Journal:  Expert Opin Ther Targets       Date:  2022-03-07       Impact factor: 6.902

6.  Crystal Structure of the Monomeric Extracellular Domain of α9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors.

Authors:  Marios Zouridakis; Athanasios Papakyriakou; Igor A Ivanov; Igor E Kasheverov; Victor Tsetlin; Socrates Tzartos; Petros Giastas
Journal:  Front Pharmacol       Date:  2019-05-01       Impact factor: 5.988

7.  Spatial Structure and Activity of Synthetic Fragments of Lynx1 and of Nicotinic Receptor Loop C Models.

Authors:  Konstantin S Mineev; Elena V Kryukova; Igor E Kasheverov; Natalia S Egorova; Maxim N Zhmak; Igor A Ivanov; Dmitry A Senko; Alexey V Feofanov; Anastasia A Ignatova; Alexander S Arseniev; Yuri N Utkin; Victor I Tsetlin
Journal:  Biomolecules       Date:  2020-12-22

8.  Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes.

Authors:  Veronika Grau; Katrin Richter; Arik J Hone; J Michael McIntosh
Journal:  Front Pharmacol       Date:  2019-01-07       Impact factor: 5.810

Review 9.  Modulation of cholinergic activity through lynx prototoxins: Implications for cognition and anxiety regulation.

Authors:  Kristin R Anderson; Katie M Hoffman; Julie M Miwa
Journal:  Neuropharmacology       Date:  2020-04-13       Impact factor: 5.250

10.  Potency- and Selectivity-Enhancing Mutations of Conotoxins for Nicotinic Acetylcholine Receptors Can Be Predicted Using Accurate Free-Energy Calculations.

Authors:  Dana Katz; Michael A DiMattia; Dan Sindhikara; Hubert Li; Nikita Abraham; Abba E Leffler
Journal:  Mar Drugs       Date:  2021-06-25       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.